Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics Inc. (DMAC) Capital Expenditures (2018 - 2019)

DiaMedica Therapeutics (DMAC) has 2 years of Capital Expenditures data on record, last reported at $14000.0 in Q4 2019.

  • For Q4 2019, Capital Expenditures rose 207.69% year-over-year to $14000.0; the TTM value through Dec 2019 reached $22000.0, down 56.0%, while the annual FY2024 figure was $25000.0, 4.17% up from the prior year.
  • Capital Expenditures reached $14000.0 in Q4 2019 per DMAC's latest filing, up from -$13000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $32000.0 in Q1 2018 and bottomed at -$13000.0 in Q4 2018.